Literature DB >> 3567102

Potential nephrotoxic effects of exposure to silver.

K D Rosenman, N Seixas, I Jacobs.   

Abstract

A cross sectional study was conducted on workers engaged in manufacturing precious metal powder. Of the 27 workers, 96% had raised urine silver concentrations (range 0.5-52.0 micrograms/l, mean 11.3 micrograms/l) and 92% had raised blood silver concentrations (range 0.05-6.2 micrograms/100 ml, mean 1.0 microgram/100 ml). Nineteen per cent also had raised urine cadmium concentrations (range 1.9-76.0 micrograms/l, mean 11.8 micrograms/l). Most workers had symptoms of respiratory irritation and nose bleeds were reported in eight (30%) of the 27 workers. Deposition of silver in the cornea of the eye was detected in five of eight (63%) of the long term workers. Although not statistically significant, corneal deposition was associated with complaints of decreased night vision. The urinary enzyme N-acetyl-B-D glucosaminidase (NAG) was significantly raised in four individuals and was correlated with blood silver concentrations and age. In addition, the group's average NAG concentration was significantly higher than that found in a control population. No association between age and urinary NAG was found in the control group. Estimated creatinine clearance was also significantly lower in the group exposed to silver than in the control group. Kidney function appears to have been adversely affected by exposures at work but because of the exposure to cadmium the role of silver in causing the decrement in kidney function could not be definitely determined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567102      PMCID: PMC1007819          DOI: 10.1136/oem.44.4.267

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  10 in total

1.  Normal concentrations of some trace metals in human urine: changes produced by ethylenediaminetetraacetate.

Authors:  H M PERRY; E F PERRY
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  An evaluation of renal function in workers occupationally exposed to mercury vapour.

Authors:  M D Stonard; B V Chater; D P Duffield; A L Nevitt; J J O'Sullivan; G T Steel
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

4.  Measurement of silver in blood by atomic-absorption spectrophotometry using the micro-cup technique.

Authors:  C Howlett; A Taylor
Journal:  Analyst       Date:  1978-09       Impact factor: 4.616

5.  The ocular manifestations and functional effects of occupational argyrosis.

Authors:  A P Moss; A Sugar; N A Hargett; A Atkin; M Wolkstein; K D Rosenman
Journal:  Arch Ophthalmol       Date:  1979-05

6.  Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy.

Authors:  M H Alderman; L Melcher; D E Drayer; M M Reidenberg
Journal:  N Engl J Med       Date:  1983-11-17       Impact factor: 91.245

7.  Assessment of renal function in workers previously exposed to cadmium.

Authors:  C G Elinder; C Edling; E Lindberg; B Kågedal; O Vesterberg
Journal:  Br J Ind Med       Date:  1985-11

8.  Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals.

Authors:  B R Meyer; A Fischbein; K Rosenman; Y Lerman; D E Drayer; M M Reidenberg
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

9.  Occupational cadmium exposure and renal status.

Authors:  F Y Falck; L J Fine; R G Smith; K D McClatchey; T Annesley; B England; A M Schork
Journal:  Am J Ind Med       Date:  1983       Impact factor: 2.214

10.  Argyria: clinical implications of exposure to silver nitrate and silver oxide.

Authors:  K D Rosenman; A Moss; S Kon
Journal:  J Occup Med       Date:  1979-06
  10 in total
  10 in total

1.  Formation of nanoscale elemental silver particles via enzymatic reduction by Geobacter sulfurreducens.

Authors:  Nicholas Law; Saadia Ansari; Francis R Livens; Joanna C Renshaw; Jonathan R Lloyd
Journal:  Appl Environ Microbiol       Date:  2008-08-22       Impact factor: 4.792

Review 2.  Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.

Authors:  Rochelle R Arvizo; Sanjib Bhattacharyya; Rachel A Kudgus; Karuna Giri; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

3.  Impact of silver(I) on the metabolism of Shewanella oneidensis.

Authors:  Hui Wang; Nicholas Law; Geraldine Pearson; Bart E van Dongen; Roger M Jarvis; Royston Goodacre; Jonathan R Lloyd
Journal:  J Bacteriol       Date:  2009-12-11       Impact factor: 3.490

4.  Urinary N-acetyl-beta-D-glucosaminidase and beta-aminoisobutyric acid in workers occupationally exposed to metals such as chromium, nickel, and iron.

Authors:  K Tomokuni; M Ichiba; Y Hirai
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

5.  Silver ion (Ag+)-induced increases in cell membrane K+ and Na+ permeability in the renal proximal tubule: reversal by thiol reagents.

Authors:  B C Kone; M Kaleta; S R Gullans
Journal:  J Membr Biol       Date:  1988-04       Impact factor: 1.843

6.  Probing structural changes in the alpha and beta domains of copper- and silver-substituted metallothionein by emission spectroscopy and electrospray ionization mass spectrometry.

Authors:  Maria T Salgado; Kristy L Bacher; Martin J Stillman
Journal:  J Biol Inorg Chem       Date:  2006-11-04       Impact factor: 3.862

7.  Acute and subchronic dermal toxicity of nanosilver in guinea pig.

Authors:  M Korani; S M Rezayat; K Gilani; S Arbabi Bidgoli; S Adeli
Journal:  Int J Nanomedicine       Date:  2011-04-27

8.  A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices.

Authors:  Alan B G Lansdown
Journal:  Adv Pharmacol Sci       Date:  2010-08-24

9.  Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles.

Authors:  Jung-Taek Kwon; Arash Minai-Tehrani; Soon-Kyung Hwang; Ji-Eun Kim; Ji-Young Shin; Kyeong-Nam Yu; Seung-Hee Chang; Dae-Seong Kim; Yong-Taek Kwon; In-Ja Choi; Yun-Hee Cheong; Jun Sung Kim; Myung-Haing Cho
Journal:  Toxicol Res       Date:  2012-03

10.  Pauci Immune crescentic glomerulonephritis in a patient with T-cell lymphoma and argyria.

Authors:  Tamer Rezk; James Penton; Anna Stevenson; Mared Owen-Casey; Mark Little; John Cunningham; Alan D Salama
Journal:  BMC Nephrol       Date:  2016-05-17       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.